To attend virtually, please click the following link: Zoom:https://baystatehealth.zoom.us/j/92482071711?pwd=kO6v0xJ0OqvFBbmCNbx1X36qY4KBLu.1&from=addon
Objectives
After participating in this educational activity, attendees should be able to:
- Understand the different WHO classifications of PH and their clinical implications.
- Differentiate Between Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Due to Left Heart Disease (PH-LHD)
- Learn how to assess disease severity in PAH using risk stratification models
- Identify When to Refer Patients to a PH Specialist
Presenter(s):
Sophia Airhart, MD
Medical Director of Pulmonary Hypertension and Regional Heart Failure
Baystate Health
| Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
|---|---|---|---|
| Sophia Airhart, MD | Speaker | Independent contractor for Alleviant | No |
The design and content of Baystate Continuing Interprofessional Education (CE) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Any relevant financial relationships are mitigated prior to the educational activity.
None of the other planners or faculty for this educational event have commercial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
- 1.00 AAPA Category 1 CME creditBaystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 IPCE Credit Hour(s)
Facebook
X
LinkedIn
Forward